SAMANTHA ADDISON: Open Payments
NPI 1053684332 · NORTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 26 payments from 10 companies in 2025. Trend: 2023 $850 · 2024 $230 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Abbott Laboratories | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $13 |
Products named: CAPLYTA, QULIPTA, VRAYLAR, UBRELVY, XIFAXAN, AIRSUPRA, COBENFY, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
